The global biomarkers market, valued at USD 57.53 billion in 2024, is expected to grow at a CAGR of 9.84% between 2025 and 2034. This growth trajectory is being shaped by evolving segment dynamics across product types, end-user industries, and application domains. As biomarkers become integral to drug development, diagnostics, and therapeutic monitoring, vendors are increasingly focusing on...
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)